Cosmederm Bioscience Introduces Steve Massah As New Chief Operating Officer

Cosmederm Bioscience, a leading specialty pharmaceutical company focused on dermatology and pain management, has hired Steve Massah as the company's new Chief Operating Officer. As COO, Massah will provide strategic and tactical leadership, and management of manufacturing, product development, quality and product shipment and logistics. His work will ensure compliance with all government regulations and industry guidelines for the company's portfolio of topical therapeutic products in the OTC, cosmeceutical skincare and prescription markets.

Suggested Articles

It’s been a minute, but AstraZeneca has gotten the FDA’s all-clear to restart the U.S. study of its COVID-19 vaccine.

Combining KSQ's USP1 inhibitor with Merck and AstraZeneca's PARP inhibitor Lynparza was more effective in animal models than either drug on its own.

Solid Bio is teaming up with Ultragenyx on Duchenne muscular dystrophy in a deal worth $40 million upfront but could net it another $255 million.